220 – Hepatitis C Virus

[1]  B. Lindenbach,et al.  Hepatitis C virus maintains infectivity for weeks after drying on inanimate surfaces at room temperature: implications for risks of transmission. , 2014, The Journal of infectious diseases.

[2]  W. Tan,et al.  The novel replication-defective vaccinia virus (Tiantan strain)-based hepatitis C virus vaccine induces robust immunity in macaques. , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

[3]  J. Ward,et al.  Testing for HCV Infection: An Update of Guidance for Clinicians and Laboratorians , 2013, MMWR. Morbidity and mortality weekly report.

[4]  Q. Park,et al.  Performance Evaluation of the OraQuick Hepatitis C Virus Rapid Antibody Test , 2013, Annals of laboratory medicine.

[5]  Y. Khudyakov,et al.  Health Care–Associated Hepatitis C Virus Infections Attributed to Narcotic Diversion , 2012, Annals of Internal Medicine.

[6]  S. Holmberg,et al.  Transmission of Hepatitis C Virus Through Transplanted Organs and Tissue – Kentucky and Massachusetts, 2011 , 2011, MMWR. Morbidity and mortality weekly report.

[7]  W. Heneine,et al.  Transmission of Human Immunodeficiency Virus and Hepatitis C Virus From an Organ Donor to Four Transplant Recipients , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[8]  P. Klenerman,et al.  Dynamic coinfection with multiple viral subtypes in acute hepatitis C. , 2010, The Journal of infectious diseases.

[9]  S. Holmberg,et al.  Is sexual contact a major mode of hepatitis C virus transmission? , 2010, Hepatology.

[10]  M. Carli,et al.  An updated follow‐up of chronic hepatitis C after three decades of observation in pediatric patients cured of malignancy , 2010, Pediatric blood & cancer.

[11]  G. Foster,et al.  Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing , 2010, Transfusion.

[12]  J. Albrecht,et al.  High sustained virologic response rates in children with chronic hepatitis C receiving peginterferon alfa-2b plus ribavirin. , 2010, Journal of hepatology.

[13]  R. Chung,et al.  Early treatment improves outcomes in acute hepatitis C virus infection: a meta‐analysis , 2010, Journal of viral hepatitis.

[14]  G. Mieli-Vergani,et al.  Chronic hepatitis C virus infection in children. , 2010, Journal of pediatric gastroenterology and nutrition.

[15]  H. Hagan,et al.  Attribution of hepatitis C virus seroconversion risk in young injection drug users in 5 US cities. , 2010, The Journal of infectious diseases.

[16]  P. Jara,et al.  Treatment of hepatitis C in children , 2010, Expert review of gastroenterology & hepatology.

[17]  Y. Jeng,et al.  Low viraemia at enrollment in children with chronic hepatitis C favours spontaneous viral clearance , 2009, Journal of viral hepatitis.

[18]  J. Santelli,et al.  Trends in sexual risk behaviors, by nonsexual risk behavior involvement, U.S. high school students, 1991-2007. , 2009, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

[19]  M. Ghany,et al.  Diagnosis, management, and treatment of hepatitis C: An update , 2009, Hepatology.

[20]  K. Reddy,et al.  Ribavirin: current role in the optimal clinical management of chronic hepatitis C. , 2009, Journal of hepatology.

[21]  A. Moorman,et al.  Nonhospital Health CareAssociated Hepatitis B and C Virus Transmission: United States, 19982008 , 2009, Annals of Internal Medicine.

[22]  D. Vlahov,et al.  Prevalence of hepatitis C virus infection among injection drug users in the United States, 1994-2004. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  G. Cabibbo,et al.  Long-term course of chronic hepatitis C in children: from viral clearance to end-stage liver disease. , 2008, Gastroenterology.

[24]  P. Rosenthal,et al.  Pathology of chronic hepatitis C in children: Liver biopsy findings in the Peds‐C Trial , 2008, Hepatology.

[25]  Carmen Díaz,et al.  Efficacy and Safety of Peginterferon-&agr;2b and Ribavirin Combination Therapy in Children With Chronic Hepatitis C Infection , 2008, The Pediatric infectious disease journal.

[26]  D. Kelly,et al.  Management Strategies for Hepatitis C Virus Infection in Children , 2008, Paediatric drugs.

[27]  T. To,et al.  Spontaneous clearance of childhood hepatitis C virus infection , 2007, Journal of viral hepatitis.

[28]  M. Figlerowicz,et al.  Adverse effects during the treatment with pegylated interferon and ribavirin in children with chronic hepatitis C , 2007, Pharmacoepidemiology and drug safety.

[29]  G. Mieli-Vergani,et al.  A National Sample of Individuals Who Acquired Hepatitis C Virus Infections in Childhood or Adolescence: Risk Factors for Advanced Disease , 2007, Journal of pediatric gastroenterology and nutrition.

[30]  A. Berrebi,et al.  HCV/HIV co-infection, HCV viral load and mode of delivery: risk factors for mother-to-child transmission of hepatitis C virus? , 2007, AIDS.

[31]  M. Alter,et al.  Infectivity of Hepatitis C Virus in Plasma After Drying and Storing at Room Temperature , 2007, Infection Control & Hospital Epidemiology.

[32]  Amita Gupta,et al.  Impact of maternal HIV coinfection on the vertical transmission of hepatitis C virus: a meta-analysis. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[33]  K. Patel,et al.  Clinical spectrum and histopathologic features of chronic hepatitis C infection in children. , 2007, The Journal of pediatrics.

[34]  M. Narkewicz,et al.  Safety, Efficacy and Pharmacokinetics of Peginterferon &agr;2a (40 kd) in Children With Chronic Hepatitis C , 2006, Journal of pediatric gastroenterology and nutrition.

[35]  G. Mieli-Vergani,et al.  Perinatal hepatitis C virus infection: diagnosis and management , 2006, Archives of Disease in Childhood.

[36]  F. Suchy,et al.  Hepatitis C in Children: A Quaternary Referral Center Perspective , 2006, Journal of pediatric gastroenterology and nutrition.

[37]  K. V. van Erpecum,et al.  The natural history of childhood‐acquired hepatitis C infection in patients with inherited bleeding disorders , 2006, Transfusion.

[38]  A. Inati,et al.  Treatment of acute hepatitis C in a child with thalassemia major using weight‐based peginterferon α‐2b , 2006, Journal of gastroenterology and hepatology.

[39]  J. Gerberding,et al.  Morbidity and Mortality Weekly Report Prevention of Hepatitis a through Active or Passive Immunization Recommendations of the Advisory Committee on Immunization Practices (acip) Centers for Disease Control and Prevention Coordinating Center for Health Information and Service Recommendations and Repo , 2022 .

[40]  M. Manns,et al.  Early monotherapy with pegylated interferon alpha‐2b for acute hepatitis C infection: The HEP‐NET acute‐HCV‐II study , 2006, Hepatology.

[41]  H. Margolis,et al.  A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents. , 2005, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[42]  J. R. Contreras,et al.  A significant sex--but not elective cesarean section--effect on mother-to-child transmission of hepatitis C virus infection , 2005 .

[43]  M. Alter,et al.  Risk factors for perinatal transmission of hepatitis C virus (HCV) and the natural history of HCV infection acquired in infancy. , 2005, The Journal of infectious diseases.

[44]  Steven R. Martin,et al.  Interferon alfa‐2b in combination with ribavirin for the treatment of chronic hepatitis C in children: Efficacy, safety, and pharmacokinetics , 2005, Hepatology.

[45]  M. Alter,et al.  Prevalence and risk factors for hepatitis C virus infection among adolescents in detention. , 2005, Archives of pediatrics & adolescent medicine.

[46]  Colin W Shepard,et al.  Global epidemiology of hepatitis C virus infection. , 2005, The Lancet. Infectious diseases.

[47]  A. Panlilio,et al.  Updated U.S. Public Health Service guidelines for the management of occupational exposures to HIV and recommendations for postexposure prophylaxis. , 2005, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[48]  A. Inati,et al.  Efficacy and tolerability of peginterferon alpha‐2a with or without ribavirin in thalassaemia major patients with chronic hepatitis C virus infection , 2005, British journal of haematology.

[49]  Y. Hiasa,et al.  Detection of hepatitis C virus (HCV) in serum and peripheral-blood mononuclear cells from HCV-monoinfected and HIV/HCV-coinfected persons. , 2005, The Journal of infectious diseases.

[50]  R. Bartenschlager,et al.  Production of infectious hepatitis C virus in tissue culture from a cloned viral genome , 2005, Nature Medicine.

[51]  G. Daikos,et al.  Mother to child transmission of hepatitis C virus: Rate of infection and risk factors , 2005, Scandinavian journal of infectious diseases.

[52]  M. Newell,et al.  When does mother to child transmission of hepatitis C virus occur? , 2005, Archives of Disease in Childhood - Fetal and Neonatal Edition.

[53]  D. Kleiner.  The liver biopsy in chronic hepatitis C: a view from the other side of the microscope. , 2005, Seminars in liver disease.

[54]  S. Polywka,et al.  Hepatitis C virus infection in pregnancy and the risk of mother-to-child transmission , 1997, European Journal of Clinical Microbiology and Infectious Diseases.

[55]  M. Newell,et al.  Three broad modalities in the natural history of vertically acquired hepatitis C virus infection. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[56]  C. García-Monzón,et al.  Diagnostic and prognostic value of virologic tests in vertical transmission of hepatitis C virus infection: results of a large prospective study in pregnant women. , 2004, Hepato-gastroenterology.

[57]  E. Neufeld,et al.  Complications of beta-thalassemia major in North America. , 2004, Blood.

[58]  J. Kalbfleisch,et al.  A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C , 2003, Hepatology.

[59]  N. Ragni,et al.  Prospective study of mother‐to‐infant transmission of hepatitis C virus: a 10‐year survey (1990–2000) , 2003, Acta obstetricia et gynecologica Scandinavica.

[60]  M. Kundi,et al.  Increased risk of mother-to-infant transmission of hepatitis C virus by intrapartum infantile exposure to maternal blood. , 2003, The Journal of infectious diseases.

[61]  G. Foster,et al.  Effects of mode of delivery and infant feeding on the risk of mother‐to‐child transmission of hepatitis C virus , 2003, BJOG : an international journal of obstetrics and gynaecology.

[62]  M. Busch,et al.  Hepatitis C virus seroconversion among young injection drug users: relationships and risks. , 2002, The Journal of infectious diseases.

[63]  R. Fontana,et al.  Noninvasive monitoring of patients with chronic hepatitis C , 2002, Hepatology.

[64]  A. Nicolucci,et al.  Effects of iron overload and hepatitis C virus positivity in determining progression of liver fibrosis in thalassemia following bone marrow transplantation. , 2002, Blood.

[65]  S. Paggi,et al.  Age at infection affects the long-term outcome of transfusion-associated chronic hepatitis C. , 2002, Blood.

[66]  F. Ansaldi,et al.  Mother‐to‐infant transmission of hepatitis C virus: Rate of infection and assessment of viral load and IgM anti‐HCV as risk factors * , 2002, Journal of medical virology.

[67]  R. Garfein,et al.  Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. , 2002, American journal of epidemiology.

[68]  G. Zuin,et al.  Maternal drug use is a preeminent risk factor for mother-to-child hepatitis C virus transmission: results from a multicenter study of 1372 mother-infant pairs. , 2002, The Journal of infectious diseases.

[69]  C. Trautwein,et al.  Treatment of acute hepatitis C with interferon alfa-2b. , 2001, The New England journal of medicine.

[70]  M. Hudson,et al.  Hepatitis C infection and hepatocellular carcinoma after treatment of childhood cancer. , 2001, Journal of pediatric hematology/oncology.

[71]  A. Francavilla,et al.  Vertical Transmission of Hepatitis C Virus in a Cohort of 2,447 HIV-Seronegative Pregnant Women: A 24-Month Prospective Study , 2001, Journal of pediatric gastroenterology and nutrition.

[72]  S. King,et al.  Mother‐to‐infant transmission of hepatitis C virus , 2001, Hepatology.

[73]  S. Sattar,et al.  Preventing the spread of hepatitis B and C viruses: where are germicides relevant? , 2001, American journal of infection control.

[74]  Eliseo Minola,et al.  Amniocentesis as a possible risk factor for mother‐to‐infant transmission of hepatitis C virus , 2001, Hepatology.

[75]  Jerome I. Tokars,et al.  Recommendations for preventing transmission of infections among chronic hemodialysis patients , 2001 .

[76]  M. Alter,et al.  Incidence and Prevalence of Chlamydia, Herpes, and Viral Hepatitis in a Homeless Adolescent Population , 2001, Sexually transmitted diseases.

[77]  T. Onodera,et al.  Prospective study of mother-to-infant transmission of hepatitis C virus. , 2001, The Pediatric infectious disease journal.

[78]  H. Souayah,et al.  Effects of mode of delivery and infant feeding on the risk of mother-to-child transmission of hepatitis C virus. European Paediatric Hepatitis C Virus Network. , 2001, BJOG : an international journal of obstetrics and gynaecology.

[79]  T. Hoshika,et al.  Prospective reevaluation of risk factors in mother-to-child transmission of hepatitis C virus: high virus load, vaginal delivery, and negative anti-NS4 antibody. , 2000, The Journal of infectious diseases.

[80]  P. Lionetti,et al.  Vertical transmission of HCV is related to maternal peripheral blood mononuclear cell infection. , 2000, Blood.

[81]  D. Gibb,et al.  Mother-to-child transmission of hepatitis C virus: evidence for preventable peripartum transmission , 2000, The Lancet.

[82]  P. Hillemanns,et al.  Obstetric risks and vertical transmission of hepatitis C virus infection in pregnancy , 2000, Acta obstetricia et gynecologica Scandinavica.

[83]  J. Salmerón,et al.  Follow‐up of transmission of hepatitis C to babies of human immunodeficiency virus‐negative women: the role of breast‐feeding in transmission , 2000, The Pediatric infectious disease journal.

[84]  M. Hudson,et al.  Hepatitis C infection among survivors of childhood cancer. , 2000, Blood.

[85]  D. Prati,et al.  Prevalence and clinical course of chronic hepatitis C virus (HCV) infection and rate of HCV vertical transmission in a cohort of 15,250 pregnant women , 2000, Hepatology.

[86]  M. Newell,et al.  Persistence rate and progression of vertically acquired hepatitis C infection. European Paediatric Hepatitis C Virus Infection. , 2000, The Journal of infectious diseases.

[87]  J. Hess,et al.  Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening. , 1999, Clinical pediatrics.

[88]  N. Berkane,et al.  Detection of hepatitis C virus RNA (HCV RNA) in amniotic fluid: a prospective study. , 1999, Journal of hepatology.

[89]  J. Sarles,et al.  Mother-to-infant transmission of hepatitis C virus: molecular evidence of superinfection by homologous virus in children. , 1999, Journal of hepatology.

[90]  A. Widell,et al.  Epidemiologic and Molecular Investigation of Outbreaks of Hepatitis C Virus Infection on a Pediatric Oncology Service , 1999, Annals of Internal Medicine.

[91]  H. Margolis,et al.  Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease , 1998 .

[92]  F. Mannelli,et al.  Mother to child transmission of hepatitis C virus: prospective study of risk factors and timing of infection in children born to women seronegative for HIV-1 , 1998, BMJ.

[93]  S. Shahul,et al.  Role of breast-feeding in transmission of hepatitis C virus to infants of HCV-infected mothers. , 1998, Journal of hepatology.

[94]  J. Goedert,et al.  Hepatitis C Virus Infection in the Mothers and Infants Cohort Study , 1998, Pediatrics.

[95]  J. Mulliken,et al.  Spastic Diplegia as a Complication of Interferon Alfa‐2a Treatment of Hemangiomas of Infancy , 1998, The Journal of pediatrics.

[96]  M. Duse,et al.  Prospective study of mother‐to‐infant transmission of hepatitis C virus (HCV) infection , 1998, Journal of medical virology.

[97]  A. Alberti,et al.  Prevalence and Natural History of Hepatitis C Infection in Patients Cured of Childhood Leukemia , 1997 .

[98]  D. Gretch.  Diagnostic tests for hepatitis C , 1997, Hepatology.

[99]  N. Principi,et al.  Increased risk of maternal-infant hepatitis C virus transmission for women coinfected with human immunodeficiency virus type 1. Italian Study Group for HCV Infection in Children. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[100]  J. Saunders,et al.  Transmission of hepatitis C virus to infants of human immunodeficiency virus‐negative intravenous drug‐using mothers: rate of infection and assessment of risk factors for transmission , 1997, Journal of viral hepatitis.

[101]  H. Tajiri,et al.  Pathology of chronic hepatitis C in children , 1997, Hepatology.

[102]  F. Rosendaal,et al.  The natural history of chronic hepatitis C in haemophiliacs , 1996, British journal of haematology.

[103]  G. Saracco,et al.  Natural history of perinatal hepatitis C virus infection. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[104]  S. Kleinman,et al.  The Risk of Transfusion-Transmitted Viral Infections , 1996 .

[105]  M. Favero,et al.  Microbiologic considerations. Disinfection and sterilization strategies and the potential for airborne transmission of bloodborne pathogens. , 1995, The Surgical clinics of North America.

[106]  H. Hsu,et al.  Absence of infection in breast-fed infants born to hepatitis C virus-infected mothers. , 1995, The Journal of pediatrics.

[107]  A. Zanetti,et al.  Mother-to-infant transmission of hepatitis C virus , 1995, The Lancet.

[108]  K. Ishak,et al.  Histopathology of Hepatitis C Virus Infection , 1995, Seminars in liver disease.

[109]  H. Mohri,et al.  Transmission of hepatitis C virus from mothers to infants: its frequency and risk factors revisited. , 1995, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[110]  N. Enomoto,et al.  Evolution and selection of hepatitis C virus variants in patients with chronic hepatitis C. , 1994, Virology.

[111]  M. Kong,et al.  Fatal hepatitis C in an infant born to a hepatitis C positive mother. , 1994, Journal of pediatric gastroenterology and nutrition.

[112]  P. Simmonds,et al.  Frequent reinfection and reactivation of hepatitis C virus genotypes in multitransfused hemophiliacs. , 1994, Journal of Infectious Diseases.

[113]  Ding‐Shinn Chen,et al.  Long term clinical and virologic outcome of primary hepatitis C virus infection in children: a prospective study. , 1994, The Pediatric infectious disease journal.

[114]  G. Faa,et al.  Effect of iron overload on the response to recombinant interferon-alfa treatment in transfusion-dependent patients with thalassemia major and chronic hepatitis C. , 1994, The Journal of pediatrics.

[115]  N. Enomoto,et al.  Fluctuation of hepatitis C virus quasispecies in persistent infection and interferon treatment revealed by single-strand conformation polymorphism analysis. , 1994, The Journal of general virology.

[116]  S. Mishiro,et al.  Transmission of Hepatitis C Virus From Mothers to Infants , 1994 .

[117]  R. Purcell,et al.  Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassaemic children , 1994, The Lancet.

[118]  R. Tedder,et al.  Hepatitis C viral RNA in clotting factor concentrates and the development of hepatitis in recipients. , 1993, Blood.

[119]  N. Ogata,et al.  Lack of protective immunity against reinfection with hepatitis C virus , 1992 .

[120]  E. Wang,et al.  Hepatitis C infection in children with hemophilia A and B. , 1991, Blood.

[121]  M. Houghton,et al.  Vertical transmission of hepatitis C virus , 1991, The Lancet.

[122]  M. Houghton,et al.  Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. , 1989, Science.